source
- Experts urge cultural shift and standards to unlock real-world evidence potential in medtechAt The MedTech Conference in Boston, experts highlighted the need for a cultural shift to build trust between regulators and medtech firms when using real-world evidence (RWE) for device marketing.…
- Celltrion licenses Kaigene's preclinical antibody KG013 in deal worth up to $580.5 millionCelltrion, a South Korean biotech, has entered into a licensing agreement with Maryland-based Kaigene for a preclinical monoclonal antibody known as KG013. KG013 is designed to block the prolifera…